A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Clinical trial NCT03871257 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03871257
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2027-12-31
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.